Literature DB >> 21562747

Regulatory mechanisms of nervous systems with glycosphingolipids.

Koichi Furukawa1, Yuhsuke Ohmi, Yuki Ohkawa, Noriyo Tokuda, Yuji Kondo, Orie Tajima, Keiko Furukawa.   

Abstract

A number of studies have suggested functions of sialic acid-containing glycosphingolipids (gangliosides) in the nervous system. However, results of analyses of the mutant mice lacking gangliosides suggested that they play crucial roles in the maintenance of integrity and repair of the nervous tissues. Furthermore, results of double knockout mice lacking all gangliosides except GM3 (GM3-only mice) suggested that deficiency of gangliosides induced complement activation and inflammation, leading to neurodegeneration. Generation of triple knockout mice by mating GM3-only mice and C3-deficient mice verified the involvement of complement systems in the inflammation and neurodegeneration. For the mechanisms of the complement activation, functional disorders of complement-regulatory proteins such as CD55 and CD59, which belong to GPI-anchored proteins, should be main factors. These results suggested that normal composition of gangliosides is essential for the maintenance of lipid rafts. Therefore, it was suggested that regulation of the complement systems and suppression of the inflammation should be important for the treatment of neurodegeneration, having common aspects with other neurodegenerative diseases such as Alzheimer disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21562747     DOI: 10.1007/s11064-011-0494-2

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  39 in total

1.  [The storage of gangliosides in nervous tissue in Tay-Sachs disease and the changes in material preserved in formalin].

Authors:  E KLENK; W VATER; G BARTSCH
Journal:  J Neurochem       Date:  1957       Impact factor: 5.372

Review 2.  Glycosphingolipids in engineered mice: insights into function.

Authors:  Koichi Furukawa; Noriyo Tokuda; Tetsuya Okuda; Orie Tajima; Keiko Furukawa
Journal:  Semin Cell Dev Biol       Date:  2004-08       Impact factor: 7.727

Review 3.  Bifunctional role of glycosphingolipids. Modulators for transmembrane signaling and mediators for cellular interactions.

Authors:  S Hakomori
Journal:  J Biol Chem       Date:  1990-11-05       Impact factor: 5.157

4.  Mice expressing only monosialoganglioside GM3 exhibit lethal audiogenic seizures.

Authors:  H Kawai; M L Allende; R Wada; M Kono; K Sango; C Deng; T Miyakawa; J N Crawley; N Werth; U Bierfreund; K Sandhoff; R L Proia
Journal:  J Biol Chem       Date:  2000-12-27       Impact factor: 5.157

Review 5.  Role of inflammation in neurodegenerative diseases.

Authors:  Luisa Minghetti
Journal:  Curr Opin Neurol       Date:  2005-06       Impact factor: 5.710

6.  Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system.

Authors:  K Takamiya; A Yamamoto; K Furukawa; S Yamashiro; M Shin; M Okada; S Fukumoto; M Haraguchi; N Takeda; K Fujimura; M Sakae; M Kishikawa; H Shiku; K Furukawa; S Aizawa
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

7.  Developmental changes in ganglioside composition and synthesis in embryonic rat brain.

Authors:  R K Yu; L J Macala; T Taki; H M Weinfield; F S Yu
Journal:  J Neurochem       Date:  1988-06       Impact factor: 5.372

8.  Postnatal development of inflammation in a murine model of Niemann-Pick type C disease: immunohistochemical observations of microglia and astroglia.

Authors:  Michel Baudry; Yuequin Yao; Danielle Simmons; Jihua Liu; Xiaoning Bi
Journal:  Exp Neurol       Date:  2003-12       Impact factor: 5.330

9.  Gangliosides GM1 and GM3 in the living cell membrane form clusters susceptible to cholesterol depletion and chilling.

Authors:  Akikazu Fujita; Jinglei Cheng; Minako Hirakawa; Koichi Furukawa; Susumu Kusunoki; Toyoshi Fujimoto
Journal:  Mol Biol Cell       Date:  2007-03-28       Impact factor: 4.138

10.  Disruption of GM2/GD2 synthase gene resulted in overt expression of 9-O-acetyl GD3 irrespective of Tis21.

Authors:  Keiko Furukawa; Wei Aixinjueluo; Takeshi Kasama; Yuki Ohkawa; Michiko Yoshihara; Yusuke Ohmi; Orie Tajima; Akio Suzumura; Daiji Kittaka; Koichi Furukawa
Journal:  J Neurochem       Date:  2008-01-14       Impact factor: 5.372

View more
  17 in total

1.  Ganglioside GD3 Enhances Invasiveness of Gliomas by Forming a Complex with Platelet-derived Growth Factor Receptor α and Yes Kinase.

Authors:  Yuki Ohkawa; Hiroyuki Momota; Akira Kato; Noboru Hashimoto; Yusuke Tsuda; Norihiro Kotani; Koichi Honke; Akio Suzumura; Keiko Furukawa; Yuhsuke Ohmi; Atsushi Natsume; Toshihiko Wakabayashi; Koichi Furukawa
Journal:  J Biol Chem       Date:  2015-05-04       Impact factor: 5.157

2.  Ganglioside GM1/galectin-dependent growth regulation in human neuroblastoma cells: special properties of bivalent galectin-4 and significance of linker length for ligand selection.

Authors:  Jürgen Kopitz; Seda Ballikaya; Sabine André; Hans-Joachim Gabius
Journal:  Neurochem Res       Date:  2012-01-11       Impact factor: 3.996

Review 3.  Functional roles of gangliosides in neurodevelopment: an overview of recent advances.

Authors:  Robert K Yu; Yi-Tzang Tsai; Toshio Ariga
Journal:  Neurochem Res       Date:  2012-03-13       Impact factor: 3.996

4.  Effects of membrane lipids on the activity and processivity of purified γ-secretase.

Authors:  Oliver Holmes; Swetha Paturi; Wenjuan Ye; Michael S Wolfe; Dennis J Selkoe
Journal:  Biochemistry       Date:  2012-04-19       Impact factor: 3.162

Review 5.  The Pathogenic Role of Ganglioside Metabolism in Alzheimer's Disease-Cholinergic Neuron-Specific Gangliosides and Neurogenesis.

Authors:  Toshio Ariga
Journal:  Mol Neurobiol       Date:  2017-01       Impact factor: 5.590

6.  Autophagy-dependent removal of α-synuclein: a novel mechanism of GM1 ganglioside neuroprotection against Parkinson's disease.

Authors:  Yu-Lin Guo; Wen-Jun Duan; Dan-Hua Lu; Xiao-Hui Ma; Xiao-Xiao Li; Zhao Li; Wei Bi; Hiroshi Kurihara; Hai-Zhi Liu; Yi-Fang Li; Rong-Rong He
Journal:  Acta Pharmacol Sin       Date:  2020-07-28       Impact factor: 6.150

7.  Lipid rafts and Alzheimer's disease: protein-lipid interactions and perturbation of signaling.

Authors:  David A Hicks; Natalia N Nalivaeva; Anthony J Turner
Journal:  Front Physiol       Date:  2012-06-22       Impact factor: 4.566

8.  Anti-ganglioside antibodies in amyotrophic lateral sclerosis revisited.

Authors:  Katja Kollewe; Ulrich Wurster; Thomas Sinzenich; Sonja Körner; Reinhard Dengler; Bahram Mohammadi; Susanne Petri
Journal:  PLoS One       Date:  2015-04-14       Impact factor: 3.240

9.  Neu3 sialidase-mediated ganglioside conversion is necessary for axon regeneration and is blocked in CNS axons.

Authors:  Sunil Kappagantula; Melissa R Andrews; Menghon Cheah; José Abad-Rodriguez; Carlos G Dotti; James W Fawcett
Journal:  J Neurosci       Date:  2014-02-12       Impact factor: 6.167

10.  Establishment of HeLa cell mutants deficient in sphingolipid-related genes using TALENs.

Authors:  Toshiyuki Yamaji; Kentaro Hanada
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.